Andrew Witty Biography
Andrew Witty is the current chief executive officer of UnitedHealth Group and a British business executive. Between 2008 and 2017, he was also the CEO of GlaxoSmithKline. He was previously the chancellor of the University of Nottingham.
Andrew Witty Age
He is 58 years old as of 2022. He was born on 22 August 1964 in the United States.
Andrew Witty Wife
He is married to Caroline M. Hall. The couple has two children.
Andrew Witty Eduction
Witty earned a bachelor’s degree in economics from the University of Nottingham after attending Malbank School, which was formerly known as “Nantwich and Acton Grammar School” in Nantwich.
Andrew Witty Optum
Witty was promoted to CEO of Optum, a UnitedHealth Group subsidiary, in July 2018. In addition to holding the position of CEO of Optum, he was given the title of president of UnitedHealth in November 2019. Witty took a one-year leave of absence from Optum in April 2020 to help the World Health Organization develop a COVID-19 vaccine. He was appointed to Patrick Vallance’s expert advisory group for the UK Government’s Vaccine Task Force in May 2020.
Andrew Witty Compensation
For this position, he receives bonuses and other compensation totaling £2,180,000 in addition to his annual salary of £948,000.
Andrew Witty Career
In 1985, Witty began working as a management trainee at Glaxo UK. He worked for Glaxo Pharmaceuticals UK as director of pharmacy and distribution, among other positions. He was in charge of strategy development, marketing execution, and new product positioning at Glaxo Wellcome Inc., a GlaxoSmithKline subsidiary. He was vice president and general manager of marketing. From 2000 to 2002, he worked as an economic advisor for the governor of Guangzhou, China.
In January 2003, he was named president of GlaxoSmithKline plc’s Pharmaceuticals Europe division. In May 2008, he succeeded Jean-Pierre Garnier as CEO. In an effort to make essential medications more affordable in low-income nations, he pledged in February 2009 to significantly alter the pricing of GSK pharmaceuticals. At the same time, he said that GSK would put some patents in a pool so that other people could use them to find new drugs. Witty was a member of the British Prime Minister David Cameron’s business advisory board from 2010 to 2015.
He was given the job of chancellor of the University of Nottingham in October 2012, which took effect on January 1, 2013. He had been close to the university ever since he graduated. In November 2017, Witty announced his retirement from the position of chancellor.
The People’s Republic of China made the announcement in July 2013 that they were looking into allegations of GSK fraud that went back to 2007 and involved thousands of millions of renminbi. “It appears that certain senior executives in the China business have acted outside of our processes and controls to both defraud the company and the Chinese health care system,” Witty stated. It is shameful to learn of these allegations against employees of GSK. They are extremely disappointing for me personally.”
Witty was a member of the UNAIDS–Lancet Commission for Defeating AIDS and Advancing Global Health from 2013 to 2015, which was co-chaired by Peter Piot, Nkosazana Dlamini Zuma, and Joyce Banda. He served as a member of Ruth Dreifuss and Festus Mogae’s UN High-Level Panel on Access to Medicines from 2015 to 2016.
Neil Woodford criticized Witty’s leadership of GSK in November 2015, stating that “he’s not doing a very good job.” Woodford proposed dividing GSK into four separate businesses. Witty announced his resignation from his position as CEO in March 2016. Witty was in charge of the National Health Service’s Accelerated Access Collaborative from 2017 to 2018.